Pharsight

Recro Gainesville patents expiration

1. Zohydro Er patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6228398 RECRO GAINESVILLE Multiparticulate modified release composition
Nov, 2019

(4 years ago)

US6902742 RECRO GAINESVILLE Multiparticulate modified release composition
Nov, 2019

(4 years ago)

US9433619 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US9421200 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US9339499 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US9326982 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US9265760 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US10456393 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US10028946 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US9610286 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US10722511 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US9333201 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US10322120 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(9 years from now)

US9486451 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(10 years from now)

US9452163 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(10 years from now)

US9713611 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(10 years from now)

US9132096 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(10 years from now)

US10092559 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(10 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Oct 25, 2016

Drugs and Companies using HYDROCODONE BITARTRATE ingredient

Market Authorisation Date: 25 October, 2013

Treatment: Treatment of pain in patients with hepatic impairment; Treatment of pain

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of ZOHYDRO ER before it's drug patent expiration?
More Information on Dosage

ZOHYDRO ER family patents

Family Patents